SGLT2 INHIBITORS REDUCE MAJOR ADVERSE CARDIOVASCULAR EVENTS IN TYPE 2 DIABETIC PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：1
|
作者：
Haris, Shamna
Singh, Sukhchain
Chaudhary, Sana
Siddiqui, Mahwash
Biko, Onyambu Steve
Singh, Sarabjeet
Hamsakutty, Haris
Khosla, Sandeep
Arora, Rohit
机构：
[1] Rosalind Franklin Univ Med & Sci, Chicago, IL USA
[2] Mt Sinai Hosp, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32284-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1743
引用
收藏
页码：1743 / 1743
页数：1
相关论文
共 50 条
  • [1] Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on major cardiovascular events in Type 2 diabetic patients: a meta-analysis of randomized controlled trials
    Bardi, Luca
    Paolillo, Stefania
    Bruzzese, Dario
    Esposito, Cristina
    Ambrosio, Antonio
    Prastaro, Maria
    Chirico, Alfonsina
    Colella, Angela
    Perrone-Filardi, Pasquale
    Gargiulo, Paola
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [2] Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on major cardiovascular events in Type 2 diabetic patients: a meta-analysis of randomized controlled trials
    Bardi, Luca
    Paolillo, Stefania
    Bruzzese, Dario
    Esposito, Cristina
    Ambrosio, Antonio
    Prastaro, Maria
    Chirico, Alfonsina
    Colella, Angela
    Perrone-Filardi, Pasquale
    Gargiulo, Paola
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [3] SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Zhao, Zinan
    Jin, Pengfei
    Zhang, Yatong
    Hu, Xin
    Tian, Chao
    Liu, Deping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [4] Effect of SGLT2 inhibitors on cardiovascular events in patients with atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials
    Zheng, Shiyue
    Lai, Yiwei
    Jiang, Chao
    He, Liu
    Zhao, Zixu
    Li, Wenjie
    Tang, Ribo
    Sang, Caihua
    Long, Deyong
    Du, Xin
    Ma, Changsheng
    Dong, Jianzeng
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2024, 47 (01): : 58 - 65
  • [5] CARDIOVASCULAR OUTCOMES OF SGLT2 INHIBITORS IN PATIENTS WITH HEART FAILURE AND OBESITY: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    De Franca, Ana
    Krause, Gustavo Pessatto
    Furtoso, Bruno
    Senter, Alexandre Moreira
    Moura, Lidia Zytynski
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 429 - 429
  • [6] Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials
    Jiang, Yu
    Yang, Pingping
    Fu, Linghua
    Sun, Lizhe
    Shen, Wen
    Wu, Qinghua
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
    Yang, Shiwen
    Liu, Ying
    Zhang, Shengzhao
    Wu, Fengbo
    Liu, Dan
    Wu, Qingfang
    Zheng, Hanrui
    Fan, Ping
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [8] Efficacy and Safety of SGLT2 Inhibitors in Patients with Type 1 Diabetes:A Meta-analysis of Randomized Controlled Trials
    Yingying Yang
    Hui Pan
    Bo Wang
    Shi Chen
    Huijuan Zhu
    Chinese Medical Sciences Journal, 2017, 32 (01) : 22 - 27
  • [9] SGLT2 inhibitors for prevention of primary and secondary cardiovascular outcomes: A meta-analysis of randomized controlled trials
    He, Guijun
    Yang, Guosu
    Huang, Xiaoyu
    Luo, Duan
    Tang, Chao
    Zhang, Zhen
    HEART & LUNG, 2023, 59 : 109 - 116
  • [10] Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials
    Li, Xuexun
    Zhang, Qian
    Zhu, Lingming
    Wang, Guangqiang
    Ge, Peipei
    Hu, Aizhen
    Sun, Xuerong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 332 : 119 - 126
12345